Pfizer Animal Health is to exercise its licensing option on Immunovaccine’s vaccine enhancement and delivery platform, in order to develop a third livestock vaccine. Pfizer agreed the first license deal, to develop cattle vaccines, in November 2009.
Immunovaccine, a Canadian biotechnology company, ...
The Moredun Research Institute (MRI) in Scotland has been awarded grants of over £1 million from the UK Government's £13m fund (Animal Pharm 679, p15) to help reduce the negative effect of livestock disease on global food security and livelihoods, particularly for farmers in developing countries. ...
The French multinational human pharma business Sanofi Aventis has indicated that it is likely to agree to a merger of its Merial business with Intervet/Schering-Plough Animal Health into a joint venture with Merck & Co . The announcement accompanied the release of Sanofi-Aventis and Merial Q4 and ...
Novartis Animal Health , the veterinary medicines business within the Swiss multinational Novartis medical group, has reported fiscal 2009 revenues of $1.101 billion in local currencies, a 4% increase on the rounded 2008 figure of $1.1bn. Animal Health is part of Novartis' Consumer Health division, ...
